XJPX
7807
Market cap23mUSD
Oct 09, Last price
916.00JPY
1D
3.15%
1Q
12.25%
Name
KOWA CO LTD
Chart & performance
P/E
8.91
P/S
0.60
EPS
102.84
Div yield, %
1.35%
Shrs. gr., 5y
-1.94%
Rev. gr., 5y
2.26%
Revenues
6.39b
+0.41%
Net income
427m
-30.65%
CFO
683m
-28.85%
Dividend
Feb 25, 202713 JPY/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Kowa Co.,Ltd., together with its subsidiaries, manufactures and sells nursing care products and welfare equipment under the Tacaof, AURULA, and GENTIL MARRONE brands in Japan. It operates through Nursing Care and Equipment Manufacturing and Sales Business, Nursing Care Service Business, and E-Commerce EC segments. The company offers walking frames, walking aid and silver carts, and walking sticks. It also offers handle lifestyle support products, such as bathing, toileting, and medication support; bathing aids; excretion care; floor-related; and food and oral care products. In addition, the company provides walking vehicles, walking assistance carts, silver cars, handrails, walking sticks, bathing products, excretion products, and life support products. Kowa Co.,Ltd. was founded in 1965 and is headquartered in Osaka, Japan.
Related entities
Subsidiaries (2)
KOWA INDIA PRIVATE LIMITED
KOWA PHARMACEUTICAL EUROPE CO. LTD.
Key people
Takayasu Miwa
Chairman & CEO
Torao Yamamoto
Executive VP, Director
Kazuyoshi Fujii
Director
Motohisa Fujimori
Director
Tetsuo Ichikawa
Director
Shuuichi Igarashi
Director
Toshio Inagi
Director
Junji Inoue
Director
Yoshiro Inoue
Director
Akihiro Miwa
Director
Hiroyuki Nakanishi
Director
Tanio Nohara
Director
Hideki Sakai
Director
Kazuo Sato
Director
Hajime Sawano
Director
Kouichi Shiraishi
Director
Kenji Ueda
Director
Akira Yamamoto
Director
Koji Yamashita
Director
Mitsuo Yoshimura
Director
Headquarters & legal address
錦三丁目６番２９号
愛知県 名古屋市中区 460-8625
JP
愛知県 名古屋市中区 460-8625
JP
Address
3-6-29,Nishiki
Nagoya,Naka-ku Aichi 460-8625
JP
Nagoya,Naka-ku Aichi 460-8625
JP
Other language
KOWA COMPANY,LTD.
Valuation
Title JPY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026‑02 | 2025‑02 | 2024‑02 | 2024‑02 | 2023‑02 | 2022‑02 | 2021‑02 | 2020‑02 | 2020‑02 | 2019‑02 | 2018‑02 | 2017‑02 | |
| Income | ||||||||||||
Revenues | ||||||||||||
Cost of revenue | ||||||||||||
Unusual Expense (Income) | ||||||||||||
NOPBT | ||||||||||||
NOPBT Margin | ||||||||||||
Operating Taxes | ||||||||||||
Tax Rate | ||||||||||||
NOPAT | ||||||||||||
Net income | ||||||||||||
Dividends | ||||||||||||
Dividend yield | ||||||||||||
Proceeds from repurchase of equity | ||||||||||||
BB yield | ||||||||||||
| Debt | ||||||||||||
Debt current | ||||||||||||
Long-term debt | ||||||||||||
Deferred revenue | ||||||||||||
Other long-term liabilities | ||||||||||||
Net debt | ||||||||||||
| Cash flow | ||||||||||||
Cash from operating activities | ||||||||||||
CAPEX | ||||||||||||
Cash from investing activities | ||||||||||||
Cash from financing activities | ||||||||||||
FCF | ||||||||||||
| Balance | ||||||||||||
Cash | ||||||||||||
Long term investments | ||||||||||||
Excess cash | ||||||||||||
Stockholders' equity | ||||||||||||
Invested Capital | ||||||||||||
ROIC | ||||||||||||
ROCE | ||||||||||||
| EV | ||||||||||||
Common stock shares outstanding | ||||||||||||
Price | ||||||||||||
Market cap | ||||||||||||
EV | ||||||||||||
EBITDA | ||||||||||||
EV/EBITDA | ||||||||||||
Interest | ||||||||||||
Interest/NOPBT | ||||||||||||